Answer
It targets mycobacterial energy production through ATP synthase and is licensed within combination treatment for pulmonary tuberculosis resistant to at least rifampicin and isoniazid.
Sources for this answer
- Sirturo 100 mg tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.